Virtus Biotech Clinical Trials ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.79
資產淨值: 42.98
成立日期: 16/12/2014
 
分析
市值分佈:
19.28%
大市值
40.56%
中市值
31.17%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 25/07/2026 05:40) 總持有投資項目: 123  
0%
 
100%
     10大 (9.93%)
代號 名稱 佔比% 持有日期
VTYX--1.2627/02/2026
DICE--1.2331/07/2023
DFTXDefinium Therapeutics Inc1.1830/06/2026
SLSSELLAS Life Sciences Group1.1730/06/2026
RGNXREGENXBIO1.1230/06/2026
CNTA--1.1129/05/2026
MNPRMonopar Therapeutics Inc0.9630/06/2026
FDMT4D Molecular Therapeutics0.9430/06/2026
APGEApogee Therapeutics0.9330/06/2026
ABCLAbCellera Biologics0.9330/06/2026
AKTSAktis Oncology Inc0.9130/06/2026
JBIOJade Biosciences Inc0.9030/06/2026
NRIXNurix Therapeutics0.8930/06/2026
MGTXMeiraGTx Holdings plc0.8730/06/2026
PVLAPalvella Therapeutics Inc0.8730/06/2026
SLDBSolid Biosciences0.8730/06/2026
NTLAIntellia Therapeutics0.8730/06/2026
BCAXBicara Therapeutics Inc.0.8530/06/2026
GENBGenerate Biomedicines, Inc.0.8530/06/2026
ORKAOruka Therapeutics Inc0.8530/06/2026
 1    2    3    4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.